Peptide medicine
Semaglutide
Semaglutide is a regulated peptide medicine with established evidence in defined indications.
- Formula
- C187H291N45O59
- Molecular weight
- 4113.58 g/mol
Evidence confidence
Human
2/5
Some human clinical evidence
1 citation
Animal
Not yet assessed
Trust Engine review pending.
Mechanistic
Not yet assessed
Trust Engine review pending — see editorial links below.
Editorial evidence links exist, but this category has not yet completed Trust Engine assessment.
Safety
2/5
Partially characterised safety
1 citation
Claimed uses
- Strong
- Strong
- Strong
Mechanisms
- not-yet-documented
- GLP-1 receptor signalling
Safety notes
Adverse effects, contraindications and monitoring requirements depend on the approved formulation and indication.
Regulation
- Approved prescription medicine in multiple jurisdictions. Brand, formulation, dose and authorised indication vary; compounded or counterfeit products are not equivalent to authorised medicines.
- Prescription or regulated medicine with jurisdiction-specific indications.
References
Last reviewed
12 July 2026